Related Experiment Video
Updated: Aug 5, 2026
09:20
Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
Published on: December 18, 2019
Dose matters: haploinsufficiency in osteogenesis imperfecta
Anastasia Sclocco1,2,3,4,5,6, Wenya Yang1,2,3,4,5, Laura Ventura1,2,3,4
1Department of Human Genetics, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
Nature Reviews. Endocrinology
|July 27, 2026
Summary
Osteogenesis imperfecta type 1, often considered mild, presents significant unrecognized burdens. Recent findings highlight distinct clinical and molecular features requiring personalized approaches for this prevalent bone fragility disorder.
Area of Science:
- Genetics
- Bone Biology
- Rare Diseases
Background:
- Osteogenesis imperfecta (OI) is a genetic bone fragility disorder with variable severity.
- Historically, research focused on deforming OI types, neglecting the prevalent OI type 1.
- Recent studies reveal substantial, unrecognized disease burdens in OI type 1 patients.
Purpose of the Study:
- To address the distinct patient group with OI type 1, recognizing diverse clinical burdens.
- To explore the genetic landscape, bone pathophysiology, disease models, and treatments for OI type 1.
- To define knowledge gaps and encourage future research into OI type 1 obscurity.
Main Methods:
- Review of recent studies (past 5 years) on Osteogenesis Imperfecta type 1.
- Analysis of clinical and molecular features distinguishing OI type 1.
- Examination of disease models and emerging therapeutic strategies.
Main Results:
- OI type 1 patients exhibit distinct clinical and molecular features, contrasting with its 'mild' classification.
- These patients face unique diagnostic and healthcare challenges due to later diagnosis and varied presentation.
- Molecular uniformity (collagen type I deficiency) characterizes OI type 1, unlike other OI types.
Conclusions:
- OI type 1 requires personalized clinical approaches and dedicated research.
- Breaking the cycle of obscurity necessitates addressing knowledge gaps in OI type 1.
- Future investigations should focus on the specific pathophysiology and treatment of OI type 1.
More Related Videos
Related Concept Videos
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
02:41Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:20Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
01:31Essential Minerals for Bone Health
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life